Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update in ventilator-associated pneumonia.

William L Jackson1, Andrew F Shorr

  • 1Critical Care Medicine Service, Department of Surgery, Walter Reed Army Medical Center, Washington, DC 20010, USA.

Current Opinion in Anaesthesiology
|March 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology and Outcomes Among Adults With Severe Community-Acquired Bacterial Pneumonia Hospitalized in the United States, 2021-2024.

Critical care medicine·2026
Same author

Ventilator-associated pneumonia: newer insights that can drive improved outcomes.

Current opinion in critical care·2026
Same author

Diagnostic Performance of Point-of-Care Immunoassay Measurements of Pancreatic Stone Protein for Sepsis Detection in ICU Patients: A Prospective, Multicenter, Biomarker-Blinded Study.

Critical care medicine·2026
Same author

Antibiotic therapy for severe bacterial infections.

Intensive care medicine·2025
Same author

The Burden of Hospitalization and Rehospitalization Among Patients Hospitalized with Severe Community-Acquired Bacterial Pneumonia in the United States, 2018-2022.

Antibiotics (Basel, Switzerland)·2025
Same author

Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.

PloS one·2025
Same journal

The evolution of nonoperating room anesthesia: navigating a new frontier.

Current opinion in anaesthesiology·2026
Same journal

Enhanced recovery pathways for patients with chronic pain: beyond standard protocols - a narrative review.

Current opinion in anaesthesiology·2026
Same journal

Novel technologies and innovations in postoperative follow-up after regional anesthesia.

Current opinion in anaesthesiology·2026
Same journal

Regional anaesthesia and analgesia in surgical patients with chronic preoperative pain: mechanisms, evidence, and clinical implications.

Current opinion in anaesthesiology·2026
Same journal

Retention in pain care and research: a narrative review focused on implanted medical devices.

Current opinion in anaesthesiology·2026
Same journal

Airway ultrasound in patients undergoing head and neck surgery.

Current opinion in anaesthesiology·2026
See all related articles

Ventilator-associated pneumonia (VAP) poses significant risks to critically ill patients, exacerbated by rising antimicrobial resistance. Recent research highlights improved diagnostic methods and targeted antibiotic strategies for VAP management.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a significant concern in intensive care units (ICUs).
  • Rising antimicrobial resistance complicates VAP prevention and treatment.
  • VAP contributes substantially to patient morbidity, mortality, and healthcare costs.

Purpose of the Study:

  • To review the latest literature on ventilator-associated pneumonia.
  • To explore advancements in VAP infection prevention strategies.
  • To examine new guidelines for VAP diagnosis and treatment.

Main Methods:

  • Literature review of recent studies on VAP.
  • Analysis of diagnostic advancements, including bronchoscopy and inflammatory markers.

Related Experiment Videos

  • Evaluation of therapeutic strategies, such as short-course antibiotics and de-escalation.

    • Main Results:

    • Studies confirm the substantial impact of VAP on ICU patient outcomes.
    • Advances in diagnostic tools offer improved VAP identification.
    • Effective management options include optimized antibiotic prescribing and de-escalation.

    Conclusions:

    • Recent research clarifies the full impact of VAP in ICUs.
    • Potential interventions for VAP are emerging.
    • Further research is needed to develop reliable preventive, diagnostic, and therapeutic strategies for VAP.